| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/17/2011 | US20110064740 Antigen binding proteins |
| 03/17/2011 | US20110064717 Homing endonuclease genes and their targets |
| 03/17/2011 | CA2773590A1 8-oxodihydropurine derivative |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295409A1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin D2 receptor antagonists |
| 03/16/2011 | EP2295069A1 Treatment of neurological disorders with haematopoietic growth factors |
| 03/16/2011 | EP2295062A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/16/2011 | EP2295049A1 Treatment of autoimmune diseases |
| 03/16/2011 | EP2294918A1 Use of a ribonuclease of the T2 family having actin-binding activity for inhibiting and/or reversing proliferation |
| 03/16/2011 | EP2294419A1 Compostions and methods for treating corneal inflammation |
| 03/16/2011 | EP2294069A1 Therapeutically useful substituted hydropyrido ý3,2,1-ij¨quinoline compounds |
| 03/16/2011 | EP2293795A1 Pharmaceutical combination |
| 03/16/2011 | EP2293794A1 Methods of treating mammals with eustachian tube dysfunctions |
| 03/16/2011 | EP1708988B1 Ibopamine maleate, method for preparing it and pharmaceutical compositions containing it |
| 03/16/2011 | EP1708987B1 L-(-)-moprolol l-(+)-tartrate |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN101986782A Substituted heteroarylamide diazepinopyrimidone derivatives |
| 03/16/2011 | CN101985464A High-stability PAC1 type receptor specific agonist MPAPO and preparation method and application thereof |
| 03/16/2011 | CN101985003A Medicinal liquor with effects of tonifying kidney and holding qi |
| 03/16/2011 | CN101590015B Cationic adhesion type mycophenolate mofetil nano eye drop |
| 03/16/2011 | CN101584689B Compound eardrops containing antipyrine and lidocaine the and preparation method thereof |
| 03/16/2011 | CN101491520B Local application medicine formulation |
| 03/15/2011 | US7906659 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 03/15/2011 | US7906650 Caspase inhibitors and uses thereof |
| 03/15/2011 | US7906644 2,4-pyrimidinediamine compounds and their uses |
| 03/15/2011 | CA2608630C Polysaccharide extract of dendrobii herba and use thereof for treating autoimmune uveitis |
| 03/15/2011 | CA2473910C Pyrimidine derivatives as rho-kinase inhibitors |
| 03/15/2011 | CA2470583C Prevention and treatment of oxidative stress disorders by glutathione and phase ii detoxification enzymes |
| 03/15/2011 | CA2431160C Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 03/15/2011 | CA2415611C Biologically active macrolides, compositions, and uses thereof |
| 03/15/2011 | CA2379575C Pharmaceutically active sulfonamide derivatives |
| 03/15/2011 | CA2360415C Benzimidazole vascular damaging agents |
| 03/10/2011 | WO2011028995A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | WO2011028797A2 Treatment of glaucoma and other retinopathies with gangliosides |
| 03/10/2011 | WO2011027916A1 Therapeutic agent for allergic diseases |
| 03/10/2011 | WO2011027778A1 Composition for topical administration to eyes for use in treatment of ocular hypertension and glaucoma |
| 03/10/2011 | WO2011027209A1 A xanthophyl composition containing macular pigments and a process for its preparation |
| 03/10/2011 | WO2010141648A3 Artificial tears and therapeutic uses |
| 03/10/2011 | WO2010130462A8 Phosphate-free pharmaceutical composition for the treatment of glaucoma |
| 03/10/2011 | WO2010130418A3 Treatment of eye diseases using encapsulated cells encoding and secreting a neuroprotective factor and/or an anti-angiogenic factor |
| 03/10/2011 | WO2010129145A3 Methods and compositions for treating dry eye |
| 03/10/2011 | US20110060045 Anti-diabetic cataract compounds and their uses |
| 03/10/2011 | US20110060041 Method of reversing, preventing, delaying or stabilizing soft tissue calcification |
| 03/10/2011 | US20110060024 Modulators of ATP-Binding Cassette Transporters |
| 03/10/2011 | US20110060012 4-[3-(aryloxy)benzylidene]-3-methyl piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |
| 03/10/2011 | US20110060006 Functionally Selective Alpha2C Adrenoreceptor Agonists |
| 03/10/2011 | US20110059999 Hydroxymethylcyclohexylamines |
| 03/10/2011 | US20110059995 Substituted xanthine derivatives |
| 03/10/2011 | US20110059970 4-phenyl-1,3-thiazoles and 4-phenyl-1,3-oxazoles derivatives as cannabinoid receptor ligands |
| 03/10/2011 | US20110059968 Carboxamide compounds and their use as calpain inhibitors |
| 03/10/2011 | US20110059959 Novel multicyclic compounds and the use thereof |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | US20110059939 Therapeutic compounds |
| 03/10/2011 | US20110059935 Beta-LACTAMYL VASOPRESSIN V1a ANTAGONISTS |
| 03/10/2011 | US20110059926 Vitamin D Compounds and Methods for Reducing Ocular Hypertension (OHT) |
| 03/10/2011 | US20110059902 Therapeutic Replenishment and Enrichment of Ocular Surface Lubrication |
| 03/10/2011 | US20110059897 Methods for treating a skin wound |
| 03/10/2011 | US20110059896 Use of furin convertase inhibitors in the treatment of fibrosis and scarring |
| 03/10/2011 | US20110059893 Compounds for the treatment of proliferative disorders |
| 03/10/2011 | US20110059167 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059142 Encapsulation of biologically active agents |
| 03/10/2011 | US20110059055 Treating myelin diseases with optimized cell preparations |
| 03/10/2011 | US20110059039 Use of peo-pbo block copolymers in ophthalmic compositions |
| 03/10/2011 | CA2772877A1 Treatment of glaucoma and other retinopathies with gangliosides |
| 03/10/2011 | CA2772718A1 Compounds as tyrosine kinase modulators |
| 03/10/2011 | CA2772097A1 Methods for treating acute acoustic trauma |
| 03/10/2011 | CA2771967A1 A xanthophyl composition containing macular pigments and a process for its preparation |
| 03/09/2011 | EP2292757A2 Treatment of eye disorders characterized by an elevated intraocular pressure by siRNAs |
| 03/09/2011 | EP2292611A1 Novel thiophenediamine derivative having urea structure |
| 03/09/2011 | EP2292610A1 Macrolides with VEGF transcription suppression activity |
| 03/09/2011 | EP2292239A2 Remedies for diseases to be applied to eye |
| 03/09/2011 | EP2292234A1 Compositions comprising quinazoline derivatives, preparation methods and uses thereof |
| 03/09/2011 | EP2292232A1 Beta-amino tetrahydroimidazo(1,2-A)pyrazines and tetrahydrotriazolo(4,3-A)pyrazines for use in the treatment of diabetes type II |
| 03/09/2011 | EP2292223A1 Polyunsaturated fatty acid supplements |
| 03/09/2011 | EP2291368A1 Substituted gamma lactams as therapeutic agents |
| 03/09/2011 | EP2291353A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents |
| 03/09/2011 | EP2291346A2 Therapeutic substituted cyclopentanes |
| 03/09/2011 | EP1827602B1 Modulating retinal pigmented epithelium permeaion by inhibiting vegfr-1 |
| 03/09/2011 | CN101983697A Nasal tampon pills for treating diabetic retinopathy |
| 03/09/2011 | CN101983656A Traditional Chinese medicine for treating diabetic eye disease |
| 03/09/2011 | CN101983647A Liquid for treating ophthalmodynia |
| 03/09/2011 | CN101983635A Juice for treating glaucoma |
| 03/09/2011 | CN101983634A Liquid for treating marginal blepharitis |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 03/08/2011 | US7901672 Methods of making enhanced, autologous fat grafts |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2434272C Novel method and composition for local treatment of meniere's disease, tinnitus and/or hearing loss |
| 03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
| 03/03/2011 | WO2011025734A1 Methods and compositions for preventing or treating ophthalmic conditions |
| 03/03/2011 | WO2011024987A1 Aromatic fused heterocyclic derivative and pharmaceutical composition containing same |
| 03/03/2011 | WO2011024932A1 Novel tetrahydroisoquinoline compounds |
| 03/03/2011 | WO2011024918A1 Antiangiogenic agent and method for inhibition of angiogenesis |
| 03/03/2011 | WO2011023805A1 Use of plasmin for the treatment of filtration failure after trabeculectomy |
| 03/03/2011 | WO2011022781A1 Treatment of macular degeneration |
| 03/03/2011 | US20110055942 Single domain TDF-related compounds and analogs thereof |
| 03/03/2011 | US20110054031 Ophthalmic NSAIDS as Adjuvants |
| 03/03/2011 | US20110054029 Water-soluble dietary fatty acids |
| 03/03/2011 | US20110054008 RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma |
| 03/03/2011 | US20110053982 Ether benzylidene piperidine 5-membered aryl carboxamide compounds useful as faah inhibitors |